Come see us at RECOMB 2022 5/22-5/25 in La Jolla, CA Poster #29 Florian Schmidt, PhD will be presenting on “Machine learning to predict viral specificity of CD8+ T cells from high throughput multi-omics data”. Click here to view our Poster at RECOMB 2022...
Michael Fehlings, PhD., ImmunoScape’s VP of Operations and Development, will be presenting on,”SARS-CoV-2 specific CD8+ T cell responses in convalescent COVID-19 individuals” on May 25 at 11:00-11:30 am PT. The CyTOF® Edge will be a half day virtual...
ImmunoScape’s Senior Director of Business Development/Lead of the Vaccine Task Force, Dr. Brian Abel did a Bio Report podcast with Daniel Levine on Characterizing the Immunome at Scale discussing a collaborative study with National Institutes of Health’s...
Geoff Nosrati, Ph.D., ImmunoScape’s Chief Business Officer, will be presenting on, “Advancing the development of next-generation therapeutics with the Deep Immunomics platform.” at Biocom’s upcoming Global Life Science Partnering Conference....
Please join our oral presentation on, “Broad and Prevalent SARS-CoV-2 CD8+ T Cell Response in Recovered COVID-19 Individuals Demonstrates Kinetics of Early Differentiation” and meet our team. Session Date: Tuesday, December 1, 2020 Session Time: 4:20 PM...
